Date | Insider | Price | Amount |
---|---|---|---|
1-29-2024 Insider Buy |
GILEAD SCIENCES, INC. >10% Owner |
$21.00 CAGR » |
$319,999,995.00 15,238,095 shares |
6-28-2023 Insider Buy |
GILEAD SCIENCES, INC. >10% Owner |
$19.26 CAGR » |
$19,452,600.00 1,010,000 shares |
4-23-2021 Insider Buy |
Yasunori Kaneko Director |
$31.37 CAGR » |
$129,652.21 4,133 shares |
3-31-2021 Insider Buy |
Kathryn E. Falberg Director |
$28.35 CAGR » |
$566,996.00 20,000 shares |
1-31-2021 Insider Buy |
Sciences Inc Gilead >10% Owner |
$39.00 CAGR » |
$220,350,000.00 5,650,000 shares |
8-10-2020 Insider Buy |
Terry J. Rosen Chief Executive Officer |
$22.86 CAGR » |
$999,313.89 43,705 shares |
7-31-2020 Insider Buy |
William Grossman Chief Medical Officer |
$19.72 CAGR » |
$3,944.56 200 shares |
10-14-2019 Insider Buy |
William Grossman Chief Medical Officer |
$8.00 CAGR » |
$3,200.00 400 shares |
6-28-2019 Insider Buy |
Juan C. Jaen President |
$7.59 CAGR » |
$113,853.60 15,000 shares |
6-13-2019 Insider Buy |
Kathryn E. Falberg Director |
$8.52 CAGR » |
$110,151.87 12,935 shares |
6-12-2019 Insider Buy |
Kathryn E. Falberg Director |
$8.20 CAGR » |
$163,928.00 20,000 shares |
6-10-2019 Insider Buy |
Kathryn E. Falberg Director |
$8.07 CAGR » |
$258,797.14 32,065 shares |
6-6-2019 Insider Buy |
Terry J. Rosen Chief Executive Officer |
$7.93 CAGR » |
$172,344.16 21,738 shares |
6-4-2019 Insider Buy |
Terry J. Rosen Chief Executive Officer |
$7.91 CAGR » |
$328,575.17 41,540 shares |
6-3-2019 Insider Buy |
Juan C. Jaen President |
$8.25 CAGR » |
$82,485.00 10,000 shares |
11-13-2018 Insider Buy |
Juan C. Jaen President |
$11.80 CAGR » |
$118,039.00 10,000 shares |
8-28-2018 Insider Buy |
Terry J. Rosen Chief Executive Officer |
$15.07 CAGR » |
$280,431.11 18,607 shares |
8-24-2018 Insider Buy |
Terry J. Rosen Chief Executive Officer |
$13.45 CAGR » |
$124,940.03 9,289 shares |
8-21-2018 Insider Buy |
Terry J. Rosen Chief Executive Officer |
$13.24 CAGR » |
$117,727.01 8,891 shares |
8-16-2018 Insider Buy |
Terry J. Rosen Chief Executive Officer |
$12.64 CAGR » |
$359,127.35 28,401 shares |
8-13-2018 Insider Buy |
Terry J. Rosen Chief Executive Officer |
$11.87 CAGR » |
$117,853.85 9,929 shares |
8-13-2018 Insider Buy |
Juan C. Jaen President |
$11.88 CAGR » |
$118,819.98 10,000 shares |
3-19-2018 Insider Buy |
Juan C. Jaen President |
$15.00 CAGR » |
$999,990.00 66,666 shares |
3-19-2018 Insider Buy |
Terry J. Rosen Chief Executive Officer |
$15.00 CAGR » |
$999,990.00 66,666 shares |
3-19-2018 Insider Buy |
Kathryn E. Falberg Director |
$15.00 CAGR » |
$450,000.00 30,000 shares |
Also See: Institutional Holders of RCUS
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 01/30/2024 | |
End date: | 04/19/2024 | |
Start price/share: | $15.72 | |
End price/share: | $14.59 | |
Dividends collected/share: | $0.00 | |
Total return: | -7.19% | |
Annualized Gain: | -33.21% | |
Starting investment: | $10,000.00 | |
Ending investment: | $9,281.00 | |
Years: | 0.22 |
RCUS Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent RCUS insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding RCUS
Free RCUS Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the RCUS Insider Buying occurred are:
BCV Insider Buying |